News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Center for Diabetes and Metabolism. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards, and honors.
09.18.2024A popular weight loss drug is psychiatrically safe for people without a history of significant mental health disorders, according to a new clinical trial published in JAMA Internal Medicine.
07.03.2024Vitamin B3 supplements may help people with peripheral artery disease walk farther, according to a Northwestern Medicine-led clinical trial published in Nature Communications.
01.30.2024A recent study from the laboratory of Joseph Bass, MD, PhD, has revealed how transcription factors within individual cells influence the identity and function of insulin-producing beta cells in the pancreas, according to findings published in Cell Metabolism.
01.17.2024Nearly two-thirds of patients with diabetes either discontinued their second-line medication, switched to a different medication class or intensified their treatment, according to a recent study.
12.19.2023Two years after the FDA’s approval of semaglutide for chronic weight management, Northwestern Medicine scientists remain at the forefront of investigating the drug’s potential in helping patients who are overweight or have obesity who also have other preexisting health conditions.
11.08.2023Tirzepatide, an antidiabetic drug, was found to be effective in helping individuals who are overweight or have obesity and without diabetes lose weight in combination with other lifestyle changes, according to a recent clinical trial published in Nature Medicine.
11.28.2022Northwestern Medicine investigators continue to study the impact of the COVID-19 pandemic on health outcomes and society, from maternal vaccinations and antibody response to reducing burnout amongst healthcare workers and identifying novel therapeutic targets.